Serena Williams’ Ozempic Transformation: Before & After Photos

The recent buzz surrounding Serena Williams’ dramatic physical transformation has extended beyond the sports world, sparking conversations about the increasing use of GLP-1 receptor agonists – often referred to by brand names like Ozempic and, more recently, Zepbound – for weight loss. While initially prescribed for managing type 2 diabetes, these medications have gained popularity for their significant weight-loss effects, attracting attention from celebrities and the public alike.

Williams publicly revealed her use of GLP-1s during a Super Bowl commercial, a move that differed sharply from many other celebrities who have been more discreet about utilizing these drugs. She has since become a global ambassador for telehealth company Ro, further placing her weight loss journey in the spotlight. According to reports from February 21, 2026, Williams has lost over 31 pounds since beginning treatment.

In an interview on Oprah’s podcast, Williams shared her struggles with postpartum weight loss, stating, “For my last match at the Open, I was literally [working out] for eight hours a day in the gym, training and I never could lose an ounce.” This candid admission highlights the challenges many individuals, even elite athletes, face when attempting to achieve weight loss through traditional methods. She also expressed feeling “lighter mentally, sexier, and more confident” after a year on the medication, as reported by Vogue.

Understanding GLP-1 Receptor Agonists

GLP-1s, such as semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Zepbound), work by mimicking the effects of the naturally occurring GLP-1 hormone. This hormone plays a role in regulating appetite and blood sugar levels. These medications slow gastric emptying, leading to a feeling of fullness, and stimulate insulin release when blood sugar is high. While effective for weight loss, it’s crucial to understand these drugs were originally developed for individuals with type 2 diabetes.

The increasing off-label use of GLP-1s for weight loss has led to supply shortages for those who rely on them for diabetes management, raising ethical concerns about access and equitable distribution. The long-term effects of these medications are still being studied, and potential side effects, such as nausea, vomiting, and diarrhea, are well-documented. Stopping the medication can also lead to weight regain, as Williams herself acknowledges, prompting questions about the sustainability of this approach to weight management.

The Role of Lifestyle and Potential Conflicts of Interest

Williams’ journey isn’t solely attributed to medication. She emphasizes combining GLP-1s with a rigorous workout routine. However, the accessibility of such a comprehensive approach – combining medication with dedicated fitness training – is limited for many. This raises questions about the potential for these medications to exacerbate existing health disparities.

Adding another layer of complexity is the financial connection between Williams’ husband, Alexis Ohanian, and Ro, the telehealth company she represents. Ohanian was an early investor in Ro and has served on their board since 2017. While not necessarily indicative of wrongdoing, this relationship presents a potential conflict of interest, particularly given Williams’ prominent role in promoting the product. Williams herself has stated, “I had never taken shortcuts in my career and always worked really hard,” but her commercials for Ro assert that “They say GLP-1s for weight loss is a shortcut. It’s not, it’s science.”

Public Perception and the Impact of Celebrity Endorsements

The public response to Williams’ transformation has been mixed. While some fans express admiration and support, others have voiced concerns about the message it sends. One Reddit user expressed feeling “devastated” and suggested that Williams’ endorsement implies something was inherently wrong with her body before, even at the peak of her athletic career. This sentiment underscores the potential for celebrity endorsements to contribute to body image issues and unrealistic expectations.

The widespread use of GLP-1s, fueled in part by celebrity endorsements, also raises broader questions about societal pressures surrounding weight and body image. While these medications can be a valuable tool for individuals struggling with obesity and related health conditions, they are not a quick fix and should be used in conjunction with lifestyle modifications, including a healthy diet and regular exercise. It’s important to remember that a healthy lifestyle is not solely defined by a number on the scale, and that body diversity should be celebrated.

Serena Williams’ experience with GLP-1s highlights the complex interplay between medical advancements, personal choices, and societal influences. As these medications become increasingly prevalent, it’s crucial to approach the topic with nuance, acknowledging both the potential benefits and the potential risks, and prioritizing a holistic approach to health and well-being.